Your Fertility Appointment Today to Start Your Family Tomorrow


You are here

Genetic Testing

Preimplantatation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) screen embryos for defects or abnormalities.

Genetic Testing Articles

Preimplantation genetic screening (PGS) is a process of screening embryos to make sure they have the right number of chromosomes and to look for any structural abnormalities in the

Preimplantation genetic diagnosis (PGD) is a laboratory procedure that is used in conjunction with in vitro fertilization (IVF) to screen for single-gene defects that may cause genetic disorders. It is a specific test offered to patients who are at a high risk of transmitting a known genetic disorder to their child.

If you’re exploring assisted reproduction technology such as in vitro fertilization (IVF), surrogacy, or egg, sperm, or embryo donation, you can have your embryos screened with preimplantation genetic screening (PGS) or preimplantation genetic diagnosis (PGD). PGS and PGD screen embryos for single gene defects or chromosomal abnormalities (extra or missing chromosomes).

Genetic Testing Videos

Who Might Consider Uterine Lavage?

Uterine lavage may provide a genetic testing option for women who may be carriers of diseases that can be inherited by their children, says Dr. Steven Nakajima, of Stanford Medicine Fertility and Reproductive Health. She must have open fallopian tubes, and can get pregnant naturally or in a stimulated cycle or with IUI.

What is Uterine Lavage?

With uterine lavage, a blastocyst that was created in vivo (in the body) is removed to for genetic testing, explains Steven Nakajima, MD, at Stanford Medicine Fertility and Reproductive Health. It could provide an alternative to genetic testing that currently is only available with IVF.

Is Uterine Lavage an Option for Genetic Screening?

With uterine lavage an embryo is created in vivo (in the body), and then removed to for genetic testing. This would allow for a non-IVF diagnosis of potential genetic diseases in embryos, explains Steven Nakajima, MD, at Stanford Medicine Fertility and Reproductive Health